2017, Número 6
Siguiente >>
Salud Mental 2017; 40 (6)
Joint statement on dual disorders: Addiction and other mental disorders
Szerman N, Martínez-Raga J, Baler R, Roncero C, Vega P, Basurte I, Grau-López L, Torrens M, Casas M, Franco C, Spinnato G, Maremmani I, Maremmani AGI, Daulouède Jean-Pierre, Aguerretxe-Colina A, Mann K, Marín-Navarrete R, Medina-Mora ME, Ruiz P
Idioma: Ingles.
Referencias bibliográficas: 38
Paginas: 245-247
Archivo PDF: 0. Kb.
FRAGMENTO
Sin resumen.
REFERENCIAS (EN ESTE ARTÍCULO)
American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (DSM-5). Arlington, VA: American Psychiatric Association. doi: 10.1176/appi.books.9780890425596.744053
Arias, F., Szerman, N., Vega, P., Mesias, B., Basurte, I., Morant, C., … & Babín, F. (2013). Madrid study on the prevalence and characteristics of outpatients with dual pathology in community mental health and substance misuse services. Adicciones, 25(2), 118-27. doi: 10.1080/17523281.2012.748674
Greenfield, S. F., & Weiss, R. D. (2015). Harvard Review of Psychiatry: Introduction. Harvard Review of Psychiatry, 23(2), 61-62. doi: 10.1097/ HRP.0000000000000074
Kessler, R. C., Hwang, I., LaBrie, R., Petukhova, M., Sampson, N., Winters, K. C., & Shaffer, H. J. (2008). DSM-IV pathological gambling in the National Comorbidity Survey Replication. Psychological Medicine, 38(9), 1351-1360. doi: 10.1017/S0033291708002900
Lev-Ran, S., Imtiaz, S., Rehm, J., & Le Foll, B. (2013). Exploring the association between lifetime prevalence of mental illness and transition from substance use to substance use disorders: Results from the National Epidemiologic Survey of Alcohol and Related Conditions (NESARC). American Journal on Addictions, 22(2), 93-98. doi:10.1111/j.1521-0391.2013.00304.x
Leyton, M., & Vezina, P. (2014). Dopamine ups and downs in vulnerability to addictions: A neurodevelopmental model. Trends in Pharmacological Sciences. doi: 10.1016/j.tips.2014.04.002
Mann, K., Roos, C., Hoffmann, S., Nakovics, H., Leméganer, T., Heinz, A., & Wictiewitz, K. (2017). Precision medicine in alcohol dependence: A controlled trial testing pharmacotherapy response among reward an relief dinking phenotype. Neuropsychopharmacology. Retrieved from: https://www.nature.com/articles/ npp2017282
Minkoff, K. (2001). Best Practices: Developing Standards of Care for Individuals With Co-occurring Psychiatric and Substance Use Disorders. Psychiatric Services, 52(5), 597-599. doi: 10.1176/appi.ps.52.5.597
National Institute on Drug Abuse. (2007). Addiction and co-occurring mental disorders.
Roncero, C., Barral, C., Rodríguez-Cintas, L., Pérez-Pazos, J., Martinez-Luna, N., Casas, M., … & Grau-López, L. (2016). Psychiatric comorbidities in opioid- dependent patients undergoing a replacement therapy programme in Spain: The PROTEUS study. Psychiatry Research, 243, 174-181. doi: 10.1016/j.psychres. 2016.06.024
Szerman, N., & Martinez-Raga, J. (2015). Editorial. Advances in Dual Diagnosis, 8(2). doi: 10.1108/ADD-03-2015-0004 Szerman, N., Martinez-raga, J., Peris, L., Roncero, C., Basurte, I., Vega, P., … & Casas, M. (2013). Rethinking Dual Disorders/Pathology. Addictive Disorders & Their Treatment, 12(1). doi: 10.1097/ADT.0b013e31826e7b6a
Van Os, J., Delespaul, P., Wigman, J., Myin-Germeys, I., & Wichers, M. (2013). Beyond DSM and ICD: Introducing “precision diagnosis” for psychiatry using momentary assessment technology. World Psychiatry, 12(2), 113-117. doi: 10.1002/wps.20046
Volkow, N. D. (2001). Drug abuse and mental illness: Progress in understanding comorbidity. American Journal of Psychiatry, 158(8), 1181-1183. doi: 10.1176/ appi.ajp.158.8.1181
Volkow, N. D., Koob, G. F., & McLellan, A. T. (2016). Neurobiologic Advances from the Brain Disease Model of Addiction. The New England Journal of Medicine, 374(4), 363-371. doi: 10.1056/NEJMra1511480
Arias, F., Szerman, N., Vega, P., Mesias, B., Basurte, I., Morant, C., …& Babin, F. (2013a). Estudio Madrid sobre prevalencia y características de los pacientes con patología dual en tratamiento en las redes de salud mental y de atención al drogodependiente. Adicciones, 25(2), 121-128. doi: 10.1016/j.rpsm.2012.09.002
Arias, F., Szerman, N., Vega, P., Mesias, B., Basurte, I., Morant, C., … & Babin, F. (2013b). Abuso o dependencia a la cocaína y otros trastornos psiquiátricos. Estudio Madrid sobre la prevalencia de la patología dual. Revista de Psiquiatría y Salud Mental, 6(3), 121-128. doi: 10.1016/j.rpsm.2012.09.002
Arias, F., Szerman, N., Vega, P., Mesias, B., Basurte, I., Morant, C., … & Babin, F. (2013c). Alcohol abuse or dependence and other psychiatric disorders. Madrid study on the prevalence of dual pathology. Mental Health and Substance Use, 6(4), 339-350. doi: 10.1080/17523281.2012.748674
Brady, K. T., Sonne, S., Randall, C. L., Adinoff, B., & Malcolm, R. (1995). Features of cocaine dependence with concurrent alcohol abuse. Drug and Alcohol Dependence, 39(1), 69-71. doi: 10.1016/0376-8716(95)01128-L
Brown, T. G., Seraganian, P., & Tremblay, J. (1994). Alcoholics also dependent on cocaine in treatment: Do they differ from “pure” alcoholics? Addictive Behaviors, 19(1), 105-112. doi: 10.1016/0306-4603(94)90056-6
Burns, L., & Teesson, M. (2002). Alcohol use disorders comorbid with anxiety, depression and drug use disorders. Findings from the Australian National Survey of Mental Health and Well Being. Drug and Alcohol Dependence, 68(3), 299- 307. doi: 10.1016/S0376-8716(02)00220-X
Calvo, N., Caseras, X., Gutiérrez, F., & Torrubia, R. (2002). Adaptación española del Personality Diagnostic Questionnaire-4+ (PDQ-4+) [Spanish version of the personality diagnostic questionnaire-4+ (PDQ-4+)]. Actas Españolas de Psiquiatría, 30(1), 7-13.
Carroll, K. M., Rounsaville, B. J., & Bryant, K. J. (1993). Alcoholism in treatment- seeking cocaine abusers: clinical and prognostic significance. Journal of Studies on Alcohol, 54(2), 199-208. doi: 10.15288/jsa.1993.54.199
Grant, B. F., & Harford, T. C. (1990). Concurrent and simultaneous use of alcohol with cocaine: results of national survey. Drug and Alcohol Dependence, 25(1), 97-104.
Hedden, S. L., Malcolm, R. J., & Latimer, W. W. (2009). Differences between adult non-drug users versus alcohol, cocaine and concurrent alcohol and cocaine problem users. Addictive Behaviors, 34(3), 323-326. doi: 10.1016/j.addbeh. 2008.11.001
Heil, S., Badger, G. J., & Higgins, S. T. (2001). Alcohol dependence among cocaine- dependent outpatients : Demographics, drug use, treatment outcome and other characteristics. Journal of Studies on Alcohol and Drugs, 62(1), 14-22. doi: 10.15288/jsa.2001.62.14
Johnson, S. D., Cottler, L. B., O’Leary, C. C., & Abdallah, A. B. (2010). The association of trauma and PTSD with the substance use profiles of alcohol- and cocaine-dependent out-of-treatment women. American Journal on Addictions, 19(6), 490-495. doi: 10.1111/j.1521-0391.2010.00075.x
Kessler, R. C., Crum, R. M., Warner, L. A., Nelson, C. B., Schulenberg, J., & Anthony, J. C. (1997). Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Archives of General Psychiatry, 54(4), 313-321. doi: 10.1001/archpsyc. 1997.01830160031005
Lecrubier, Y., Sheehan, D. V., Weiller, E., Amorim, P., Bonora, I., Harnett Sheehan, K., … & Dunbar, G. C. (1997). The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. European Psychiatry, 12(5), 224-231. doi: 10.1016/ S0924-9338(97)83296-8
Moss, H. B., Goldstein, R. B., Chen, C. M., & Yi, H.-Y. (2015). Patterns of use of other drugs among those with alcohol dependence: Associations with drinking behavior and psychopathology. Addictive Behaviors, 50, 192-198. doi: 10.1016/j. addbeh.2015.06.041
Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L., & Goodwin, F. K. (1990). Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA, 264(19), 2476-2598. doi: 10.1001/jama.1990.03450190043026
Sheehan, D. V, Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., … & Dunbar, G. C. (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. The Journal of Clinical Psychiatry, 59(20), 22-33.
Stinson, F. S., Grant, B. F., Dawson, D. A., Ruan, W. J., Huang, B., & Saha, T. (2005). Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug and Alcohol Dependence, 80(1), 105-116. doi: 10.1016/j.drugalcdep.2005.03.009
Suttajit, S., Kittirattanapaiboon, P., Junsirimongkol, B., Likhitsathian, S., & Srisurapanont, M. (2012). Risks of major depressive disorder and anxiety disorders among Thais with alcohol use disorders and illicit drug use: Findings from the 2008 Thai National Mental Health survey. Addictive Behaviors, 37(12), 1395- 1399. doi: 10.1016/j.addbeh.2012.06.014
Vanek, V. W., Dickey-White, H. I., Signs, S. A., Schechter, M. D., Buss, T., & Kulics, A. T. (1996). Concurrent use of cocaine and alcohol by patients treated in the emergency department. Annals of Emergency Medicine, 28(5), 508-514. doi: 10.1016/S0196-0644(96)70114-2
Volkow, N. D. (2007). Addiction and co-ocurring mental disorders. Director’s perspective. National Institute on Drug Abuse, 21(2).
Walsh, D. C., Hingson, R. W., Merrigan, D. M., Cupples, L. A., Levenson, S. M., & Coffman, G. A. (1991). Associations between alcohol and cocaine use in a sample of problem-drinking employees. Journal of Studies on Alcohol and Drugs, 52(1), 17-25. doi: 10.15288/jsa.1991.52.17
Weaver, T., Madden, P., Charles, V., Stimson, G., Renton, A., Tyrer, P., … & Ford, C. (2003). Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. The British Journal of Psychiatry, 183(4), 304-313.
Windle, M., & Miller-Tutzauer, C. (1991). Antecedents and correlates of alcohol, cocaine, and alcohol-cocaine abuse in early adulthood. Journal of Drug Education, 21(2), 133-148. doi: 10.2190/F497-8GKY-0U31-XMJJ